Evidence map›Paper›PMID 41255802›Full record

ArticleJournal of clinical practice and research2023

Prevalence of Post-COVID-19 Syndrome and Related Factors among University Employees: A Prospective Cohort Study.

Feyza Nehir Öznur Muz, Selma Metintaş, Muhammed Fatih Önsüz, Alaettin Ünsal, Didem Arslantaş, Ali Kılınç, Selva Dilan Gölbaşı Koç, Sevda Sungur

Abstract read
In one paragraph

Article in Journal of clinical practice and research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Feyza Nehir Öznur MuzDepartment of Public Health, Eskişehir Osmangazi University Faculty of Medicine, Eskişehir, Türkiye.
Selma MetintaşDepartment of Public Health, Eskişehir Osmangazi University Faculty of Medicine, Eskişehir, Türkiye.
Muhammed Fatih ÖnsüzDepartment of Public Health, Eskişehir Osmangazi University Faculty of Medicine, Eskişehir, Türkiye.
Alaettin ÜnsalDepartment of Public Health, Eskişehir Osmangazi University Faculty of Medicine, Eskişehir, Türkiye.
Didem ArslantaşDepartment of Public Health, Eskişehir Osmangazi University Faculty of Medicine, Eskişehir, Türkiye.
Ali KılınçDepartment of Public Health, Eskişehir Osmangazi University Faculty of Medicine, Eskişehir, Türkiye.
Selva Dilan Gölbaşı KoçDepartment of Public Health, Eskişehir Osmangazi University Faculty of Medicine, Eskişehir, Türkiye.
Sevda SungurDepartment of Public Health, Eskişehir Osmangazi University Faculty of Medicine, Eskişehir, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The term post-COVID (coronavirus disease) is used to refer to the presence of prolonged symptoms 12 weeks or more after the disease treatment. This study aimed to evaluate the presence of symptoms and anxiety in patients with COVID-19 who did not require inpatient care at the third and sixth months following symptom onset. Materials and Methods: The study is a prospective cohort study involving 471 university employees who contracted COVID-19 between October 2020 and October 2021. Data were obtained through the disease contact follow-up program implemented at the university and phone interviews conducted at the third and sixth months from symptom onset. Results: The study group comprised 361 individuals at three months and 109 at six months from symptom onset. The study found that symptoms persisted in 116 (32.1%) people in the third month and in 47 (13.0%) people in the sixth month. The most common symptoms at three months were shortness of breath, fatigue, and fatigue, while fatigue, fatigue, and shortness of breath were the most common symptoms at six months. Conclusion: Understanding the long-term effects of coronavirus will enhance the management of the disease. As a result, the follow-up of symptomatic COVID-19 and post-COVID-19 patients will become more systematic and effective.

Indexed as

common symptomsCOVID-19Post-COVID Syndromeprospective cohort studySARS-CoV-2

Identifiers

PMID41255802
PMCPMC12478737

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.